
Regain density and reshape your hairline with physician-led, minimally invasive Follicular Unit Excision (FUE) powered by the ARTAS® iXi robotic system. ARTAS uses AI, machine vision, and a 7-axis robotic arm to identify and harvest optimal grafts and create recipient sites with consistent precision—delivering natural-looking results without a linear scar. Venus AI Venus Concept
Book a Consult
We combine robotic accuracy with regenerative medicine to create a smoother experience and exceptional outcomes.
ARTAS® iXi is an intelligent robotic hair restoration platform that assists your physician across key steps of FUE: selecting robust donor follicles, harvesting them with high repeatability, and creating/implanting recipient sites according to your personalized plan. It features a multi-camera stereoscopic vision system with ~44-micron resolution and a seven-axis robotic arm to deliver consistent, accurate results. Venus AIVenus Concept

Regulatory note: ARTAS® iXi is FDA-cleared and licensed by Health Canada with indications that include assisting physicians with identifying and extracting follicular units, creating recipient sites, and implanting harvested follicles. Specific U.S. labeling includes use in men with black or brown straight hair diagnosed with androgenic alopecia. Your candidacy is evaluated during consultation. Venus Treatmentsvga-asia.com

We’ll review your goals, donor capacity, medical history, and hair characteristics to build a realistic plan.
Discomfort is usually minimal with local anesthesia. Most patients describe post-procedure soreness that resolves quickly.
ARTAS FUE does not create a single linear scar; instead, it leaves tiny dot-like extraction sites that typically become hard to detect after healing. Venus ConceptVenus Treatments
Transplanted hairs commonly shed first, then begin growing in a few months, with fuller results developing across 6–12 months.
Candidacy depends on donor supply, hair characteristics, and goals. We’ll assess during your consultation and may recommend alternatives if needed.
We focus on evidence-based, physician-guided care. Supportive therapies are included where appropriate; your plan will outline any suggested adjuncts.
Artas Hair Transplant Video #1
Artas iXi AI Robotic hair transplant #2
The Glucose-6-Phosphate Dehydrogenase (G6PD) Test measures enzyme activity to detect G6PD deficiency, a genetic condition that can lead to hemolytic anemia when exposed to certain foods, infections, or medications. Doctors order this test to assess unexplained anemia, jaundice, or family history of G6PD deficiency. Results help identify individuals at risk for red blood cell breakdown, guiding treatment, prevention, and safe medication use.
Specimen: Blood
Collection: Blood Draw
Also Known As: Glucose-6-Phosphate Dehydrogenase Test, G6PD Enzyme Test, G6PD Deficiency Test
Book NowThe SARS-CoV-2 Total Antibody Spike Semi-Quantitative Test detects antibodies to the COVID-19 spike protein, indicating an adaptive immune response from recent or prior infection. Vaccinated individuals may also test positive, though results should not be used to assess immunity or protection. Doctors use this blood test to confirm past exposure, but it is not designed to diagnose active infection or predict reinfection risk.
Specimen: Blood
Collection: Blood Draw
Also Known As: COVID-19 Spike Test
Book Now